Markets · Global Equities · US
Aardvark Therapeutics, Inc. AARD
Exchange Nasdaq. Sector Pharma & biotech. Source: SEC companyfacts. Not a price feed.
- Revenue TTM 3.53M
- EBITDA TTM -71.06M
- Net debt —
- ND/EBITDA —
- EBITDA/interest —
- ROE -0.89
- Implied band